Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Blackburn

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Molecular and Cellular Cardiology|May 1, 1984
Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonistsA J Higgins, K J Blackburn
Journal of Cardiovascular Pharmacology|January 1, 1992
Dofetilide, a novel class III antiarrhythmic agentH S Rasmussen, M J Allen, K J Blackburn, et al.
European Journal of Pharmacology|May 14, 1992
Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogsM Gwilt, K J Blackburn, R A Burges, et al.
Journal of Cardiovascular Pharmacology|March 1, 1991
Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agentM Gwilt, H W Dalrymple, R A Burges, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cellsM Gwilt, J E Arrowsmith, K J Blackburn, et al.
Journal of Medicinal Chemistry|September 1, 1986
Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituentsJ E Arrowsmith, S F Campbell, P E Cross, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptorsR A Burges, D G Gardiner, M Gwilt, et al.
American Heart Journal|September 1, 1981
Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failureC R Taylor, J R Baird, K J Blackburn, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Molecular and Cellular Cardiology|May 1, 1984
Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonistsA J Higgins, K J Blackburn
Journal of Cardiovascular Pharmacology|January 1, 1992
Dofetilide, a novel class III antiarrhythmic agentH S Rasmussen, M J Allen, K J Blackburn, et al.
European Journal of Pharmacology|May 14, 1992
Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogsM Gwilt, K J Blackburn, R A Burges, et al.
Journal of Cardiovascular Pharmacology|March 1, 1991
Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agentM Gwilt, H W Dalrymple, R A Burges, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cellsM Gwilt, J E Arrowsmith, K J Blackburn, et al.
Journal of Medicinal Chemistry|September 1, 1986
Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituentsJ E Arrowsmith, S F Campbell, P E Cross, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptorsR A Burges, D G Gardiner, M Gwilt, et al.
American Heart Journal|September 1, 1981
Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failureC R Taylor, J R Baird, K J Blackburn, et al.
Pageof 1